ns 1619 has been researched along with Pulmonary Arterial Remodeling in 1 studies
NS 1619: structure given in first source
NS 1619 : A member of the class of benzimidazoles that is 1,3-dihydro-2H-benzimidazol-2-one in which the hydrogens at positions 1 and 5 are replaced are replaced by 2-hydroxy-5-(trifluoromethyl)phenyl and trifluoromethyl groups, respectively. It is an opener/activator of the large-conductance calcium-activated potassium channel (Bkca).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, M | 1 |
| Yin, X | 1 |
| Li, S | 1 |
| Zhang, X | 1 |
| Yi, M | 1 |
| He, C | 1 |
| Li, X | 1 |
| Wang, W | 1 |
| Zhang, S | 1 |
| Liu, H | 1 |
1 other study available for ns 1619 and Pulmonary Arterial Remodeling
| Article | Year |
|---|---|
Large-Conductance Calcium-Activated Potassium Channel Opener, NS1619, Protects Against Mesenteric Artery Remodeling Induced by Agonistic Autoantibodies Against the Angiotensin II Type 1 Receptor.
Topics: Animals; Autoantibodies; Benzimidazoles; Calcium; Calcium, Dietary; HEK293 Cells; Humans; Large-Cond | 2022 |